Ultra Nasdaq Biotechnology 2X ETF (BIB)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

macrossluvsrobotech
macrossluvsrobotech Jan. 7 at 3:27 AM
$CMPS Laying the groundwork ... News Today: Plus Investor Meeting Tomorrow: "Radial is building a national network of clinics across the U.S., delivering interventional, evidence-based treatments for mental health conditions. The co-founders have a mission-driven background in designing customer-centric care and building systems to enable operational scalability. Most notably, executive chairman Elliot Cohen co-founded PillPack, an e-commerce pharmacy sold to Amazon to become Amazon Pharmacy. Radial currently operates across five states and provides virtual assessments across the U.S. Together, Compass and Radial will explore how investigational COMP360 synthetic psilocybin treatment will fit into a growing national network of clinics such as Radial’s, with the aim of enabling a seamless integration at launch." https://finance.yahoo.com/news/compass-pathways-establishes-strategic-collaboration-113000360.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAAIKgBSZ5jd8U-RDluqrgMvGng2ii4QhfEEksut1pXaD6FaV5a4t3R5azmlAwehgC14Tc1ZosX2-qdlDpu5HZ6LFtXLrw_CX-TIq4wjtOw_sMEp9rp24_ZVarvGH4J2xIRGCAQsvf6pjvakh0PZu8OoRKNFZFKhHKbLxFhcFQtur Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Host-Webinar-on-Commercial-Preparations-for-Treatment-Resistant-Depression-TRD-and-Clinical-Trial-Plans-for-Post-Traumatic-Stress-Disorder-PTSD-on-January-7-2026-1000am-ET/default.aspx $ATAI $MNMD $BIB
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 5 at 6:09 PM
$BIB RSI: 40.15, MACD: 0.6778 Vol: 1.97, MA20: 80.20, MA50: 76.77 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SaltSpeculator
SaltSpeculator Dec. 25 at 9:24 AM
$BIB Risk premia compress only when proof accumulates, since capital markets reward discipline over expansion for its own sake. The upside case requires evidence, not projection.
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 24 at 9:01 AM
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year $ABVX $BIB https://stocktwits.com/news/equity/markets/how-abivax-went-from-biotech-nobody-to-m-and-a-bullseye-after-a-single-blockbuster-readout/cLeso3JREHu
2 · Reply
2kaykim
2kaykim Nov. 26 at 5:37 PM
HOLY HELL+85% MOVE SINCE THE APRIL LOWS $XBI $IBB $LABU $BIB #BIOTECH
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Nov. 18 at 5:26 PM
$CMPS @SecKennedy Please watch: Psylocibin needs to be legalized as a therapy for Veterans and for the general public: Please watch this recent Netflix special: https://youtu.be/ao8tiqnuS3Y?si=TS13nrkwpReFTwhP @COMPASSPathway @ataibeckley are pioneers in this field. Please see their pipelines and please communicate with @MartyMakary and @US_FDA and have them also watch this documented Psylocibin therapeutics later confirm and validated with Stanford Brain analysis of pre and post treatment: https://scitechdaily.com/ibogaines-impact-alleviating-ptsd-depression-and-anxiety-in-special-ops-military-vets-with-traumatic-brain-injury/ $ATAI $BIB
0 · Reply
DinoMcnuggets
DinoMcnuggets Nov. 17 at 10:16 PM
$XBI $IBB $LABU $BIB Where were all the pumpers at 70? Now they are drawing triple bottom charts, and calling for a breakout AFTER the majority of the move has happened. Fundamentals are turning massively bearish for biotech again, with the TNX/DXY entering a new uptrend. Inflation is not contained, and the fed has officially given up. XBI Is overvalued by about 20 points at these based on the TIPS market. Buyout mania is bolstering valuations, but buyout mania is always a retail trap. When big pharma closes their pocket books, fundamentals will take over real fast.
4 · Reply
JFDI
JFDI Nov. 17 at 5:49 PM
$BIB $IBB $LABU $XBI
0 · Reply
2kaykim
2kaykim Nov. 17 at 5:46 PM
Biotech breaking out after putting in MULTI-YEAR TRIPLE BOTTOM. Biotech is +70% since the April lows & 50% away from 2021-ATH level $XBI $IBB $LABU $BIB
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Nov. 14 at 3:06 AM
$LXRX Rotation into Biotech and Pharma out of AI is happening. Don't let them take your shares. $BIB $GILD
0 · Reply
Latest News on BIB
Investing In Health Stocks - How Policy Clarity Is Opening Doors

Nov 11, 2025, 10:13 AM EST - 2 months ago

Investing In Health Stocks - How Policy Clarity Is Opening Doors

AGNG ARKG BBC BBH BBP BIS BMED

BIB: A Tactical 2 X Leveraged Biotech ETF

Oct 23, 2025, 8:00 AM EDT - 2 months ago

BIB: A Tactical 2 X Leveraged Biotech ETF

Healthcare Sector Checkup As U.S. Looks To Change Regulations

May 30, 2025, 3:30 PM EDT - 7 months ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

AGNG ARKG BBC BBH BBP BIS BMED

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Feb 25, 2025, 11:06 AM EST - 11 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

IBB XLV AGNG ARKG BBC BBH BBP

Will The Next Batch Of Tech Earnings Encourage Investors To Rotate Back In?

Jul 30, 2024, 2:30 AM EDT - 1 year ago

Will The Next Batch Of Tech Earnings Encourage Investors To Rotate Back In?

AAPL AMZN ANSS BA FFIV GOOGL HSY

Equity CEFs/ETFs: Top Picks For 2024 - Part II

Jan 5, 2024, 11:01 AM EST - 2 years ago

Equity CEFs/ETFs: Top Picks For 2024 - Part II

AIO AIQ DIG EOI ETW EXG HQH

Why Now Could Be The Time To Consider Neuroscience Investments

Aug 27, 2022, 4:45 AM EDT - 3 years ago

Why Now Could Be The Time To Consider Neuroscience Investments

ARKG BBH FBT GNOM HELX IBB IBBQ

macrossluvsrobotech
macrossluvsrobotech Jan. 7 at 3:27 AM
$CMPS Laying the groundwork ... News Today: Plus Investor Meeting Tomorrow: "Radial is building a national network of clinics across the U.S., delivering interventional, evidence-based treatments for mental health conditions. The co-founders have a mission-driven background in designing customer-centric care and building systems to enable operational scalability. Most notably, executive chairman Elliot Cohen co-founded PillPack, an e-commerce pharmacy sold to Amazon to become Amazon Pharmacy. Radial currently operates across five states and provides virtual assessments across the U.S. Together, Compass and Radial will explore how investigational COMP360 synthetic psilocybin treatment will fit into a growing national network of clinics such as Radial’s, with the aim of enabling a seamless integration at launch." https://finance.yahoo.com/news/compass-pathways-establishes-strategic-collaboration-113000360.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAAIKgBSZ5jd8U-RDluqrgMvGng2ii4QhfEEksut1pXaD6FaV5a4t3R5azmlAwehgC14Tc1ZosX2-qdlDpu5HZ6LFtXLrw_CX-TIq4wjtOw_sMEp9rp24_ZVarvGH4J2xIRGCAQsvf6pjvakh0PZu8OoRKNFZFKhHKbLxFhcFQtur Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Host-Webinar-on-Commercial-Preparations-for-Treatment-Resistant-Depression-TRD-and-Clinical-Trial-Plans-for-Post-Traumatic-Stress-Disorder-PTSD-on-January-7-2026-1000am-ET/default.aspx $ATAI $MNMD $BIB
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 5 at 6:09 PM
$BIB RSI: 40.15, MACD: 0.6778 Vol: 1.97, MA20: 80.20, MA50: 76.77 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SaltSpeculator
SaltSpeculator Dec. 25 at 9:24 AM
$BIB Risk premia compress only when proof accumulates, since capital markets reward discipline over expansion for its own sake. The upside case requires evidence, not projection.
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 24 at 9:01 AM
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year $ABVX $BIB https://stocktwits.com/news/equity/markets/how-abivax-went-from-biotech-nobody-to-m-and-a-bullseye-after-a-single-blockbuster-readout/cLeso3JREHu
2 · Reply
2kaykim
2kaykim Nov. 26 at 5:37 PM
HOLY HELL+85% MOVE SINCE THE APRIL LOWS $XBI $IBB $LABU $BIB #BIOTECH
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Nov. 18 at 5:26 PM
$CMPS @SecKennedy Please watch: Psylocibin needs to be legalized as a therapy for Veterans and for the general public: Please watch this recent Netflix special: https://youtu.be/ao8tiqnuS3Y?si=TS13nrkwpReFTwhP @COMPASSPathway @ataibeckley are pioneers in this field. Please see their pipelines and please communicate with @MartyMakary and @US_FDA and have them also watch this documented Psylocibin therapeutics later confirm and validated with Stanford Brain analysis of pre and post treatment: https://scitechdaily.com/ibogaines-impact-alleviating-ptsd-depression-and-anxiety-in-special-ops-military-vets-with-traumatic-brain-injury/ $ATAI $BIB
0 · Reply
DinoMcnuggets
DinoMcnuggets Nov. 17 at 10:16 PM
$XBI $IBB $LABU $BIB Where were all the pumpers at 70? Now they are drawing triple bottom charts, and calling for a breakout AFTER the majority of the move has happened. Fundamentals are turning massively bearish for biotech again, with the TNX/DXY entering a new uptrend. Inflation is not contained, and the fed has officially given up. XBI Is overvalued by about 20 points at these based on the TIPS market. Buyout mania is bolstering valuations, but buyout mania is always a retail trap. When big pharma closes their pocket books, fundamentals will take over real fast.
4 · Reply
JFDI
JFDI Nov. 17 at 5:49 PM
$BIB $IBB $LABU $XBI
0 · Reply
2kaykim
2kaykim Nov. 17 at 5:46 PM
Biotech breaking out after putting in MULTI-YEAR TRIPLE BOTTOM. Biotech is +70% since the April lows & 50% away from 2021-ATH level $XBI $IBB $LABU $BIB
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Nov. 14 at 3:06 AM
$LXRX Rotation into Biotech and Pharma out of AI is happening. Don't let them take your shares. $BIB $GILD
0 · Reply
wolverine
wolverine Nov. 11 at 9:03 PM
$CRMD man look at those 6 month charts for the $XBI $IBB $BIB and look at that run by Cormedix? Our time will come?
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 3:34 PM
$BIB $BITQ $BKCH $BMEA $BRKR 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 27 at 9:37 PM
🔥 $BRKR $BMEA $BKCH $BITQ $BIB 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:48 PM
$BFS $BHC $BHR $BIB $BIGY 🔥
0 · Reply
Peachtreegal
Peachtreegal Oct. 17 at 3:35 PM
$ARTV $IBBQ $BIB
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 17 at 3:27 PM
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally $ARTV $IBBQ $BIB https://stocktwits.com/news/equity/markets/artiva-biotherapeutics-gets-price-target-hike-from-wedbush/ch6sW9tR38A
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 16 at 3:22 PM
$FBIO + ( $DERM ) Older copper injections, sometimes prepared in-house, could be painful and, with long-term use, could cause kidney damage. In clinical trials for CUTX-101, adverse events were generally not considered related to the study treatment, highlighting its improved safety profile. Enhanced bioavailability and safety The specific formulation of CUTX-101 ensures better delivery of copper to the body and brain, where it is critically needed. CUTX-101 has been granted Breakthrough Therapy, Fast Track, Rare Pediatric Disease, and Orphan Drug designations. These designations recognize the drug's potential to provide significant clinical improvement over existing treatments for a rare condition with unmet medical needs. $DERM ( subsidiary of $FBIO OWNS ACCUTANE, see screenshots and link for how it helps treat male infertility . https://www.livescience.com/health/fertility-pregnancy-birth/acne-drug-accutane-may-restore-sperm-production-in-infertile-men-early-study-hints $BIB $JNJ
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 10:58 PM
$FBIO Updated link, more here: For more info on FIRST EVER TREATMENT for MENKES Disease, a Pediatric, often Fatal Condition, Pending Sept 30th PDUFA for $FBIO. And for latest Isotretinoin and Male Infertility Treatment studies, using Istotretinoin, AKA, ACCUTANE, which is owned by $DERM, a subsidiary of $FBIO, that can treat Male Infertility, based on recent studies. See link below and read quoted post below . https://x.com/ravagelaserbeak/status/1967719314229997659 Related tickers: $DERM $BIB $JNJ $MRK
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 8:31 PM
$FBIO + $DERM ($DERM is a subsidiary of $FBIO ) Aside from Sept 30th PDUFA = we have this = " For men with infertility caused by extremely low sperm counts or a complete lack of sperm, the only medical option is to undergo surgery to collect sperm directly from the testicles to then use for in vitro fertilization (IVF). But this is a significant surgery that involves discomfort; potential risks, such as infection; and a prolonged recovery period. Moreover, the surgery only yields sperm about half the time. Now, researchers are exploring an alternative: isotretinoin, better known as Accutane, a drug that has been used for decades to treat severe acne. In a small study published in July in the Journal of Assisted Reproduction and Genetics, the drug stimulated sperm production in some men who at baseline had no or very few sperm in their ejaculate. " Good Post on $FBIO More here = https://x.com/ravagelaserbeak/status/1967686200199889335?s=46 related tickers = $BIB $DERM $PFE $JNJ
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 3 at 4:58 PM
$GOOGL OH and we have our own Blockchain now to compete against $XRP lol.... and we're also $BIB on Pharma Treatment discovery by a Nobel Prize Laureate leading Google Deepmind, Demis Hassabis. Long. Price correcting up, now that Browser hurdle has been cleared, likely supports around 350+ in a few weeks. This is re-rate and has ZERO to do with Macro environments. The ONLY thing that had this down is eviscerated and completely gone.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Aug. 27 at 3:13 PM
$SSYS Im long $SSYS with Debbie Wasserman Schultz...Debbie Knows...things.... Stratasys posted this about 10 minutes ago = Regenerated Dead Nerve cells in spinal due to precise 3D printed spinal scaffold... "Printing the scaffold lets researchers pattern guidance channels and place cells precisely—creating a “relay” that can bypass damaged tissue. Early-stage, but a credible path toward translational implants. Read: https://medicalxpress.com/news/2025-08-3d-scaffold-spinal-cord-injury.html " $BIB $JNJ
2 · Reply
SparkySC
SparkySC Jul. 2 at 3:44 AM
$SPY $QQQ $BIB $PFE $TLT WOW! A must read… https://www.vigilantfox.com/p/rfk-jr-unloads-disturbing-vaccine
1 · Reply